3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders
Cancers of the head and neck can be treated with several drugs on the market, but for certain patients diagnosed ...
Tuesday, February 4, 2025
Tag: Biotech
Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
Biotech Financing Roundup: Jade Bio’s Launch, Brenig’s Debut, Confo’s Cash & More
One challenge for developing drugs for autoimmune diseases is that biologic therapies can spark an immune response against them. Immunology ...
Inflammation Biotech Alumis Trims IPO Plans But Still Raises $250M for Clinical Trials
Immunology and inflammation biotech Alumis has demonstrated its lead drug candidate can hit a certain validated target to treat plaque ...
AI Biotech Exscientia Fires CEO Hopkins for Relationships With Two Employees
Exscientia founder and CEO Andrew Hopkins is out of a job after an investigation found the CEO engaged in relationships ...
Genetic Medicines Biotech Dyne Pulls In $345M for Clinical Tests of Muscle Drugs
Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of ...
Goldman Sachs Closes $650M Fund to Invest in ‘Golden Era’ of Biotech Innovation
Goldman Sachs Asset Management has expanded to biotech investments in recent years. The investment firm is now preparing to ramp ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.